It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Sleep is essential to life. Accurate measurement and classification of sleep/wake and sleep stages is important in clinical studies for sleep disorder diagnoses and in the interpretation of data from consumer devices for monitoring physical and mental well-being. Existing non-polysomnography sleep classification techniques mainly rely on heuristic methods developed in relatively small cohorts. Thus, we aimed to establish the accuracy of wrist-worn accelerometers for sleep stage classification and subsequently describe the association between sleep duration and efficiency (proportion of total time asleep when in bed) with mortality outcomes. We developed a self-supervised deep neural network for sleep stage classification using concurrent laboratory-based polysomnography and accelerometry. After exclusion, 1113 participant nights of data were used for training. The difference between polysomnography and the model classifications on the external validation was 48.2 min (95% limits of agreement (LoA): −50.3 to 146.8 min) for total sleep duration, −17.1 min for REM duration (95% LoA: −56.7 to 91.0 min) and 31.1 min (95% LoA: −67.3 to 129.5 min) for NREM duration. The sleep classifier was deployed in the UK Biobank with ~100,000 participants to study the association of sleep duration and sleep efficiency with all-cause mortality. Among 66,262 UK Biobank participants, 1644 mortality events were observed. Short sleepers (<6 h) had a higher risk of mortality compared to participants with normal sleep duration 6–7.9 h, regardless of whether they had low sleep efficiency (Hazard ratios (HRs): 1.36; 95% confidence intervals (CIs): 1.18 to 1.58) or high sleep efficiency (HRs: 1.29; 95% CIs: 1.04–1.61). Deep-learning-based sleep classification using accelerometers has a fair to moderate agreement with polysomnography. Our findings suggest that having short overnight sleep confers mortality risk irrespective of sleep continuity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Oxford, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
2 University of Leicester, Diabetes Research Centre, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411)
3 Flinders University, College of Medicine and Public Health, Adelaide, Australia (GRID:grid.1014.4) (ISNI:0000 0004 0367 2697)
4 University of Western Australia, Centre of Sleep Science, School of Human Sciences, Perth, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); Sir Charles Gairdner Hospital, West Australian Sleep Disorders Research Institute, Department of Pulmonary Physiology, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942)
5 University of Pennsylvania, Department of Genetics, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
6 University of Pennsylvania, Department of Psychiatry, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
7 University of Leicester, Diabetes Research Centre, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411); University of Leicester, NIHR Leicester Biomedical Research Centre, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411)
8 John Radcliffe Hospital, NIHR Oxford Biomedical Research Centre, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492); University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford Kavli Centre for Nanoscience Discovery, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
9 University of Oxford, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Medical Research Council Population Health Research Unit, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
10 Curtin University, Curtin School of Allied Health, Perth, Australia (GRID:grid.1032.0) (ISNI:0000 0004 0375 4078)
11 Murdoch University, Health Futures Institute, Murdoch, Australia (GRID:grid.1025.6) (ISNI:0000 0004 0436 6763)
12 University of Oxford, Sir Jules Thorn Sleep & Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)